Eosinophilic Granulomatosis with Polyangiitis (EGPA)

Diagnosis and management of Churg-Strauss syndrome.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
RheumatologyVasculitisRespiratory

Clinical Guidelines

2025 British Society for Rheumatology management guideline for eosinophilic granulomatosis with polyangiitis (EGPA)
National
EULAR recommendations for the management of ANCA-associated vasculitis
National
Executive summary: The 2025 British Society for Rheumatology management guideline for eosinophilic granulomatosis with polyangiitis (EGPA)
National
KDIGO 2024 Clinical Practice Guideline For The Management Of ANCA Vasculitis
National
NICE guideline [TA845]: Mepolizumab for treating eosinophilic granulomatosis with polyangiitis
National
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Local
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Local
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Local
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Local
New 2025 British Society for Rheumatology (BSR) management guideline for eosinophilic granulomatosis with polyangiitis (EGPA)
Local